1551 – 1560 of 1632
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2004
-
Mark
Experience, Contractual Covenants and Venture Capitalists’ Responses to Unmet Expectations
2004)(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Responses to psychological contract violation in the venture capital – entrepreneur relationship: An exploratory study
(
- Contribution to journal › Article
-
Mark
Quality Assessment of the Copernicus Institute for Sustainable Development and Innovation at Utrecht University
2004)(
- Book/Report › Report
-
Mark
Contractual Covenants and Venture Capitalists’ Responses to Unmet Expectations
2004) Babson-Kauffman Entrepreneurship Research Conference, 2004(
- Contribution to conference › Paper, not in proceeding
-
Mark
The role of IPRs in biotechnology innovations
2004) DRUID winter conference, 2004(
- Contribution to conference › Paper, not in proceeding
-
Mark
The making of innovation systems in least developed countries. Evidence from Tanzania.
2004) DRUID Summer conference on Industrial Dynamics, Innovation and Development, 2004(
- Contribution to conference › Paper, not in proceeding
-
Mark
Einzelhandelsentwicklung und Raumplanung in Polen
2004) In RaumPlanung(
- Contribution to journal › Article
-
Mark
Business Angels’ Investment Preferences: Early-stage Investors – Are They Different?
2004) RENT XVIII Research in Entrepreneurship Conference(
- Contribution to conference › Paper, not in proceeding
-
Mark
The Systemic Nature of Innovation – Causes and Implications
2004) Conference “Research, Innovation and Economic Performance – What do we Know and Where are We Heading?” organised by the European Commission, the Centre for Technology, Innovation and Culture of the University of Oslo, and Oxford University Press to mark the launch of the Oxford Handbook of Innovation(
- Contribution to conference › Paper, not in proceeding
-
Mark
Intellectual Property Rights: Necessary but insufficient incentives to encourage R & D in the biopharmaceutical industry. The case of neglected diseases.
2004) DRUID Summer conference on Industrial Dynamics, Innovation and Development, 2004(
- Contribution to conference › Paper, not in proceeding